Alcon Opens Manufacturing Plant in Singapore to Produce Ophthalmic Pharmaceutical Products

SINGAPORE—On April 14, Alcon officially opened its new $200 million, 330,000-square-foot pharmaceutical manufacturing facility in the Tuas Biomedical Park. Located here to be closer to Alcon’s growing base of customers in Asia, the plant produces ophthalmic pharmaceutical products which address eye conditions such as glaucoma, dry eye, allergies and bacterial infections.   See more